ArticleAdvanced pharmaceutical bulletin2020

Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells.

Azam Akbari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.